BridgeMD
New treatment option for Chest Pain
Official title ECG-less Coronary Computed Tomography Angiography in the Management of Patients Presenting With High-troponin Chest Pain
ClinicalTrials.gov ID: NCT07192965
What this study is testing
- What it's testing
- Chest pain represents a common reason for consultation to emergency room. This symptom can be explained by a broad spectrum of conditions, from benign musculoskeletal or esophageal pain to life-threatening disease such as aortic dissection, pulmonary embolism, and myocardial infarction.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 and older
You may be able to join if
- Age ≥ 30 years old
- Admission at the ER with acute chest pain and at least one of the follow-ing:
- ECG abnormality;
- positive rule-in criteria according to the ESC guidelines (hs-cTnT ≥ 52 in at least one assay or 1h ∆ ≥ 5);
- troponine value in the "observe pathway" (hs-cTnT ≥ 12 in at least one assay or 1h ∆ ≥ 3) AND a high clinical suspicion of MI.
You likely can't join if
- Indication for urgent ICA (ST-elevation, hemodynamic or electric instabil-ity, refractory chest pain, mechanical complications)
- eGFR \< 30 ml/min
- Previous coronary stenting
- Previous CABG
- Recent ACS within 6 months
- Known severely reduced ejection fraction (EF \< 30%)
See the full eligibility criteria
- Age ≥ 30 years old
- Admission at the ER with acute chest pain and at least one of the follow-ing:
- ECG abnormality;
- positive rule-in criteria according to the ESC guidelines (hs-cTnT ≥ 52 in at least one assay or 1h ∆ ≥ 5);
- troponine value in the "observe pathway" (hs-cTnT ≥ 12 in at least one assay or 1h ∆ ≥ 3) AND a high clinical suspicion of MI.
- Indication for urgent ICA (ST-elevation, hemodynamic or electric instabil-ity, refractory chest pain, mechanical complications)
- eGFR \< 30 ml/min
- Previous coronary stenting
- Previous CABG
- Recent ACS within 6 months
- Known severely reduced ejection fraction (EF \< 30%)
- Contrast allergy
- Inability to provide informed consent
- Limited life expectancy \< 2 years due to non-cardiac conditions
- Pregnant and breast-feeding women
- Known congenital heart disease
- Atrial fibrillation
The study team makes the final eligibility decision.
Where it's taking place
- Jette, Belgium
Compensation & support
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jette, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.